3billion, Inc. (KOSDAQ: A394800)
Health Care · Biotechnology · KR
₩6,230.00
-1.89% today · -1.1% 1Y
3billion, Inc. (KOSDAQ: A394800) operates in the Biotechnology industry within the Health Care sector. The company is valued at $140.25M.
Over the last twelve months the share price has lost 1.1%, trading between 4.26K and 20.10K.
Tweenvest scores 3billion, Inc. across four factors: quality 34/100, value 63/100, growth 100/100. Its strongest factor is growth.
A394800 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $140.25M
- Revenue (TTM)
- $8.11M
- P/E
- —
- EPS
- -171.00
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩20,100.00
- 52-week low
- ₩4,260.00
- Avg volume (3M)
- —
- Shares outstanding
- 31.82M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.